(Q79157997)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

Ryuichiro Kumasaka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Norio Nakamura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Kenichi Shirato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Takeshi Fujita

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Reiichi Murakami

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Michiko Shimada

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Masayuki Nakamura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Hiroshi Osawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Hideaki Yamabe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Ken Okumura

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

Clinical and experimental nephrology

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

222-225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10157-006-0424-9

20 December 2019

exact match

0 references

cites work

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

Molecular pathogenesis of multiple sclerosis

1 reference

12 December 2020

Beta-interferon-induced nephrotic syndrome in a patient with multiple sclerosis

1 reference

12 December 2020

Nephrotic syndrome in a multiple sclerosis patient treated with interferon beta 1a

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Recurrent nephrotic syndrome in patient with multiple sclerosis treated with interferon beta-1a

1 reference

12 December 2020

Minimal change nephrotic syndrome developing during postoperative interferon-beta therapy for malignant melanoma

1 reference

12 December 2020

Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results

1 reference

12 December 2020

Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS

1 reference

12 December 2020

Pathogenesis of tissue injury in MS lesions

1 reference

12 December 2020

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

12 December 2020

Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells

1 reference

12 December 2020

10.1007/S10157-006-0424-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009081%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference